RxDoctor Payments Data

Arjun Ramesh, MD

Interventional Pain Medicine · Dubuque, IANPI 1487034419

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.5%), food and beverage and grants — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Abbott at 36.8% of the total.

$23,745in general payments, 2019–2025

Across 388 payments — averaging $61.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$9K
  • Medtronic$5K
  • Boston Scientific$3K
  • Biotronik NRO, Inc.$2K
  • Nevro Corp.$2K
  • Globus Medical$1K
  • plus $1K from 17 others

What the payments were for

  • Grants$750%
  • Travel & lodging$11,99751%
  • Food & beverage$11,65249%
  • Education$210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few interventional pain medicine providers in Iowato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$99,745
Medicare patients
171
Services billed
1,660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin23$433
Tizanidine Hcl18$140
Methylprednisolone20$113
Diclofenac Sodium11$75

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Dubuque

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →